Common use of SUCCESSOR LIABILITY Clause in Contracts

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics Diversicare proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Diversicare shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Diversicare wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Diversicare must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Healogics Post Acute Medical proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Post Acute Medical shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Post Acute Medical wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Post Acute Medical must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics Lincare proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Lincare shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If Lincare wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics Lincare must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics CHN proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics CHN shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If CHN wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics CHN must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics UHS proposes to (a) sell any or all of its behavioral health business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new behavioral health business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any behavioral health business, business unit, or location and any new behavioral health business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics UHS shall give notice of such sale or purchase to OIG within at least 30 days following prior to the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics UHS wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics UHS must notify OIG in writing of the proposed sale or purchase and include the following information at least 30 days in advance. This notification shall include : a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics Progenity proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Progenity shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. Progenity, Inc. Corporate Integrity Agreement If, in advance of a proposed sale or a proposed purchase, Healogics Progenity wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Progenity must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics Numotion proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Numotion shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If Numotion wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics Numotion must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.purchaser.‌

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics proposes the Parties propose to (a) sell any or all of its their business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics The Parties shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics wishes location. If the Parties wish to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of CIA requirements, the CIA, Healogics Parties must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics Renew proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Renew shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If Xxxxx wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics Renew must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics CCH proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics CCH shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If CCH wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics CCH must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event thatIf, after the Effective Date, Healogics Rockport proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Rockport shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If Rockport wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics Rockport must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics Ventura County proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Ventura County shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Ventura County wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition Ventura County Corporate Integrity Agreement will not be subject to the requirements of the CIA, Healogics Ventura County must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that‌ If, after the Effective Date, Healogics Provider proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Provider shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If Provider wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics Provider must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that‌ If, after the Effective Date, Healogics TEN proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics TEN shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If TEN wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics TEN must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that‌ If, after the Effective Date, Healogics Provider proposes to (a) sell any or all of its businessbusiness , business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Provider shall give notice notify OIG, in writing, of such sale or purchase to OIG within 30 days following the closing of the transaction. Iftransaction and shall notify OIG, in advance writing, within 30 days of a proposed sale establishing such new business, business unit, or a proposed purchase, Healogics location. If Provider wishes to obtain a determination by OIG that the a proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIACIA requirements, Healogics Provider must notify OIG in writing at least 30 days in advance of the proposed sale or purchase at least 30 days in advancepurchase. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics SMMC proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics SMMC shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics SMMC wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not San Mateo Medical Center Corporate Integrity Agreement be subject to the requirements of the CIA, Healogics SMMC must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. ‌ In the event that, after the Effective Date, Healogics Providence proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Providence shall give notice of such sale or purchase to OIG within at least 30 days following prior to the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Providence wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Providence must notify OIG in writing of the proposed sale or purchase and include the following information at least 30 days in advance. This notification shall include : a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics the Rush Organization proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics The Rush Organization shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics the Rush Organization wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics the Rush Organization must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics Oglethorpe proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, ; or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Oglethorpe shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Oglethorpe wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Oglethorpe must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics Millcreek proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Millcreek shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Xxxxxxxxx wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Xxxxxxxxx must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.

SUCCESSOR LIABILITY. In the event that, after the Effective Date, Healogics Vascular Access Centers proposes to (a) sell any or all of its business, business units, or locations (whether through a sale of assets, sale of stock, or other type of transaction) relating to the furnishing of items or services that may be reimbursed by a Federal health care program, or (b) purchase or establish a new business, business unit, or location relating to the furnishing of items or services that may be reimbursed by a Federal health care program, the CIA shall be binding on the purchaser of any business, business unit, or location and any new business, business unit, or location (and all Covered Persons at each new business, business unit, or location) shall be subject to the applicable requirements of this CIA, unless otherwise determined and agreed to in writing by OIG. Healogics Vascular Access Centers shall give notice of such sale or purchase to OIG within 30 days following the closing of the transaction. If, in advance of a proposed sale or a proposed purchase, Healogics Vascular Access Centers wishes to obtain a determination by OIG that the proposed purchaser or the proposed acquisition will not be subject to the requirements of the CIA, Healogics Vascular Access Centers must notify OIG in writing of the proposed sale or purchase at least 30 days in advance. This notification shall include a description of the business, business unit, or location to be sold or purchased, a brief description of the terms of the transaction and, in the case of a proposed sale, the name and contact information of the prospective purchaser.